of our journey
HOW DOES IT WORK?
You can directly support our growth story from the beginning and be a financial sponsor and value appreciation partner.
Akribion Genomics is currently executing Series A financing. We are looking for investors which believe in our mission that genome editing enables the biotech revolution.
WHY SHOULD YOU INVEST?
High value potential
Strong growth with highly attractive licensing opportunity
Attractive therapeutic area focus, novel solution
Big impact on patients and largest TA by sales
Already licensed and used in Contract R&D
Strong and committed team
Seasoned mgmt. team and entrepreneurial R&D team
De-risked business model
Adjacent segments with early & existing revenues
Customers and partners
GET IN TOUCH
NEWS & PUBLICATIONS